Rosenband is dedicated to pharmaceutical liability, personal injury, and product liability
A Differentiated Next-Generation GLP Candidate SureNano Science is advancing GEP-44 as a patented, next-generation metabolic therapy intended to improve upon limitations associated with first-generation GLP-1 drugs, positioning this emerging microcap as a minnow among giants quickly transitioning through the FDA pathway
Does Retatrutide work for prediabetes
Unlike older weight loss medicines that often act on the brain or must be taken daily, retatrutide is not psychoactive and strikes directly at metabolic pathways
Peptides 77:2837 Holst JJ et al (2018) Mechanisms in bariatric surgery: gut hormones, diabetes resolution, and weight loss
This "three-pronged" approach is why it is so effective at stripping fat off the liver, which Dr